All Stories

  1. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals
  2. Age-specific differences in the dynamics of protective immunity to influenza
  3. Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015
  4. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity
  5. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong
  6. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia
  7. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
  8. Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015
  9. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1
  10. Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015
  11. Coronavirus infections in horses in Saudi Arabia and Oman
  12. A46 MERS-CoV in Arabian camels in Africa and Central Asia
  13. Serum 25-Hydroxyvitamin D Was Not Associated with Influenza Virus Infection in Children and Adults in Hong Kong, 2009–2010
  14. Quantifying homologous and heterologous antibody titre rises after influenza virus infection
  15. Absence of Middle East Respiratory Syndrome Coronavirus in Camelids, Kazakhstan, 2015
  16. Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera
  17. Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity
  18. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015
  19. Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015
  20. Asymptomatic MERS-CoV Infection in Humans Possibly Linked to Infected Dromedaries Imported from Oman to United Arab Emirates, May 2015
  21. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
  22. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection
  23. Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  24. Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014
  25. International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
  26. Determinants of serum 25-hydroxyvitamin D in Hong Kong
  27. Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels
  28. Immunology and Immunopathology of emerging viral disease
  29. Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
  30. MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia
  31. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
  32. MERS Coronaviruses in Dromedary Camels, Egypt
  33. Incidence of Influenza Virus Infections in Children in Hong Kong in a 3-Year Randomized Placebo-Controlled Vaccine Study, 2009-2012
  34. Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children
  35. Inferring Influenza Infection Attack Rate from Seroprevalence Data
  36. Association Between Antibody Titers and Protection Against Influenza Virus Infection Within Households
  37. Comparison of two laboratory extraction techniques for the detection of Epstein-Barr virus in the saliva of nasopharyngeal carcinoma patients
  38. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
  39. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
  40. Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong
  41. Seroconversion to Pandemic (H1N1) 2009 Virus and Cross-Reactive Immunity to Other Swine Influenza Viruses
  42. Seroconversion to Pandemic (H1N1) 2009 Virus and Cross-Reactive Immunity to Other Swine Influenza Viruses
  43. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy
  44. Long-term evolution and transmission dynamics of swine influenza A virus
  45. Identification of differential pharyngeal cytokine profiles during HIV infection
  46. Shedding dynamics of Epstein-Barr virus: A type 1 carcinogen
  47. Pattern of traumatic dental injuries in children attending the University Dental Hospital, Sri Lanka
  48. Epstein-barr virus shedding and cytokine alterations in the oropharynx during HIV-1 infection
  49. Virologic and sero-epidemiological studies of Middle East respiratory syndrome coronavirus (MERS-COv) infections in dromedary camels in Nigeria